Publication Cover
Xenobiotica
the fate of foreign compounds in biological systems
Latest Articles
57
Views
0
CrossRef citations to date
0
Altmetric
Review Article

Through a computer monitor darkly: artificial intelligence in absorption, distribution, metabolism and excretion science.

, &
Received 06 Oct 2023, Accepted 12 Dec 2023, Accepted author version posted online: 14 Dec 2023
Accepted author version

References

  • Bender A, Cortés-Ciriano I. 2021a. Artificial intelligence in drug discovery: what is realistic, what are illusions? Part 1: Ways to make an impact, and why we are not there yet. Drug Discovery Today. 26(2):511-524.
  • Bender A, Cortes-Ciriano I.2021b. Artificial intelligence in drug discovery: what is realistic, what are illusions? Part 2: a discussion of chemical and biological data. Drug Discovery Today. 26(4):1040-1052.
  • Benet LZ, Hoener BA. 2002. Changes in plasma protein binding have little clinical relevance. Clin Pharm Therap 71(3):15-121.
  • Benet LZ, Sodhi JK. 2020. Investigating the theoretical basis for in vitro–in vivo extrapolation (ivive) in predicting drug metabolic clearance and proposing future experimental pathways. AAPS J. 22(5):120.
  • Chan P, Van Gerven T, Dubois, JL, Bernaerts K. 2021. Virtual chemical laboratories: A systematic literature review of research, technologies and instructional design. Computers and Education Open, 2:100053.
  • Chen S, Li T, Yang L, Zhai F, Jiang X, Xiang R, Ling G.2022. Artificial intelligence-driven prediction of multiple drug interactions. Briefings in Bioinformatics, 23(6): bbac427.
  • Chou WC, Lin Z.2023. Machine learning and artificial intelligence in physiologically based pharmacokinetic modeling. Toxicol Sci.191(1):1-14.
  • Creanza TM, Delre P, Ancona N, Lentini G, Saviano M, Mangiatordi GF.2021. Structure- based prediction of hERG-related cardiotoxicity: A benchmark study. J Chem Inf. Model. 61(9):4758-4770.
  • Devagiri JS, Paheding S, Niyaz Q, Yang X, Smith S. 2022. Augmented Reality and Artificial Intelligence in industry: Trends, tools, and future challenges. Expert Systems with Applications: 18002.
  • Fourches D, Muratov E, Tropsha, A, 2010. Trust, but verify: on the importance of chemical structure curation in cheminformatics and QSAR modeling research. J Chem Inf. Model. 50(7):1189.
  • Gandhi YA, Morris ME. 2012. Reevaluation of a quantitative structure pharmacokinetic model for biliary excretion in rats. Drug Met Disp. 40(7):1259-1262.
  • Gao CA, Howard FM, Markov NS, Dyer EC, Ramesh S, Luo Y, Pearson AT.2022. Comparing scientific abstracts generated by ChatGPT to original abstracts using an artificial intelligence output detector, plagiarism detector, and blinded human reviewers. BioRxiv: 2022-12.
  • Gupta R, Srivastava D, Sahu M, Tiwari S, Ambasta RK, Kumar P, 2021. Artificial intelligence to deep learning: machine intelligence approach for drug discovery. Molecular Diversity. 25:1315-1360.
  • Hassani H, Silva ES, Unger S, TajMazinani M, Mac Feely S. 2020. Artificial intelligence (AI) or intelligence augmentation (IA): what is the future? Ai. 1(2):8.
  • Iwata H, Matsuo T, Mamada H, Motomura T, Matsushita M, Fujiwara T, Maeda K, Handa K. 2022. Predicting total drug clearance and volumes of distribution using the machine learning-mediated multimodal method through the imputation of various nonclinical data. J Chem Inf Model. 62(17):4057-4065.
  • King MR, ChatGPT.2023. A conversation on artificial intelligence, chatbots, and plagiarism in higher education. Cell Mol Bioengineering. 6(1):1-2.
  • Kirchmair J,Williamson MJ, Tyzack JD, Tan L, Bond PJ, Bender A, Glen RC. 2012. Computational prediction of metabolism: sites, products, SAR, P450 enzyme dynamics, and mechanisms. J Chem Inf Model. 52(3):617-648.
  • Hauben M. 2023. Artificial Intelligence and Data Mining for the Pharmacovigilance of Drug– Drug Interactions. ClinTherap. S0149-2918.
  • Hines PA, Guy RH, Humphreys AJ, Papaluca-Amati M. 2019. The European Medicines Agency’s goals for regulatory science to 2025. Nature Rev Drug Disc.18(6):403-404.
  • Kimoto E, Bi, YA, Kosa RE, Tremaine LM, Varma MV. 2017. Hepatobiliary clearance prediction: species scaling from monkey, dog, and rat, and in vitro–in vivo extrapolation of sandwich-cultured human hepatocytes using 17 drugs. J Pharm Sci. 106(9): 2795-2804.
  • Lalik K, Wątorek F. 2021. Predictive maintenance neural control algorithm for defect detection of the power plants rotating machines using augmented reality goggles. Energies, 14(22):7632.
  • Lee JW, Maria-Solano MA, Vu TNL, Yoon S, Choi, S. 2022. Big data and artificial intelligence (AI) methodologies for computer-aided drug design (CADD). Biochem Soc Trans. 50(1): 241-252.
  • Liu G, Catacutan DB, Rathod K, Swanson, K., Jin W, Mohammed J C, Chiappino-Pepe, A, Syed SA, Fragis M, Rachwalski K., Magolan, J. 2023. Deep learning-guided discovery of an antibiotic targeting Acinetobacter baumannii. Nature Chem Biol. May 25th: 1-9.
  • Lombardo F, Obach RS, Shalaeva MY, Gao F. 2002. Prediction of volume of distribution values in humans for neutral and basic drugs using physicochemical measurements and plasma protein binding data. J Med Chem. 45(13):2867-2876.
  • Lombardo F, Waters NJ, Argikar UA, Dennehy MK, Zhan J, Gunduz M, Harriman SP, ,Berellini G, Rajlic IL, Obach, RS. 2013a. Comprehensive assessment of human pharmacokinetic prediction based on in vivo animal pharmacokinetic data, part 1: volume of distribution at steady state. J Clin.Pharm. 53(2):167-177.
  • Lombardo F, Waters NJ, Argikar UA, Dennehy MK, Zhan J, Gunduz M, Harriman SP, Berellini,G, Rajlic, IL, Obach RS. 2013b. Comprehensive assessment of human pharmacokinetic prediction based on in vivo animal pharmacokinetic data, part 2: clearance. J Clin Pharm. 53(2):178–191.
  • Lombardo F, Jing, Y. 2016. In silico prediction of volume of distribution in humans. Extensive data set and the exploration of linear and nonlinear methods coupled with molecular interaction fields descriptors. J Chem Inf Model. 56(10):2042-2052.
  • MacKrill K. 2023. Impact of media coverage on side effect reports from the COVID-19 vaccine. J. Psych. Res.164: .111093.
  • Martin GL, Jouganous J, Savidan R, Bellec A, Goehrs C, Benkebil M, Miremont G Micallef J, Salvo F, Pariente A, Létinier L. 2022. Validation of artificial intelligence to support the automatic coding of patient adverse drug reaction reports, using nationwide pharmacovigilance data. Drug Safety, 45(5):535-548.
  • Mulhall A, de Louvois J, Hurley R. 1983. Chloramphenicol toxicity in neonates: its incidence and prevention. Br Med. J (Clin Res Ed.), 287(6403):1424-1427.
  • Obach RS. 1999. Prediction of human clearance of twenty-nine drugs from hepatic microsomal intrinsic clearance data: an examination of in vitro half-life approach and nonspecific binding to microsomes. Drug Met Disp.27(11): 350-1359.
  • Obrezanova,O. 2023. Artificial intelligence for compound pharmacokinetics prediction. Curr Opin.Structural Biol.79: 102546.
  • O’Donovan DH, De Fusco C, Kuhnke L, Reichel A. 2023. Trends in Molecular Properties, Bioavailability, and Permeability across the Bayer Compound Collection: Miniperspective. J Med Chem. 66(4):2347-2360.
  • Öeren M, Hunt PA, Wharrick CE, Tabatabaei-Ghomi H, Segall MD. 2023. Predicting routes of phase I and II metabolism based on quantum mechanics and machine learning. Xenobiotica, (just-accepted): 1-49.
  • Øie S, Tozer TN. 1979. Effect of altered plasma protein binding on apparent volume of distribution. J Pharm Sci. 68(9):1203-1205.
  • Paul D, SanapG, Shenoy S, Kalyane D, Kalia K, Tekade R.K. 2021. Artificial intelligence in drug discovery and development. Drug Disc Today. 26(1):.80
  • Press B, Di Grandi D.2008. Permeability for intestinal absorption: Caco-2 assay and related issues. Current Drug Met. 9(9):893-900.
  • Ruzickova E, Skoupa N, Dolezel P, Smith, DA, Mlejnek P. 2019. The lysosomal sequestration of tyrosine kinase inhibitors and drug resistance. Biomolecules. 9(11): 675.
  • Schneckener S, Grimbs S, Hey, J, Menz S, Osmers M., Schaper S, Hillisch A, Göller, AH. 2019. Prediction of oral bioavailability in rats: Transferring insights from in vitro correlations to (deep) machine learning models using in silico model outputs and chemical structure parameters. J Chem Inf.Model.59. (11):4893-4905.
  • Seery MK. 2020. Establishing the laboratory as the place to learn how to do chemistry. J Chem Ed. 97(6):1511-1514.
  • Smith DA, Beaumont K, Maurer TS. Di L. 2015. Volume of distribution in drug design: miniperspective. J Med Chem. 58(15):5691-5698.
  • Smith DA, Beaumont K, Maurer TS, Di L. 2018. Clearance in drug design: miniperspective. J Med Chem. 62(5):2245-2255.
  • Smith DA. Jones BC. 1992. Speculations on the substrate structure-activity relationship (SSAR) of cytochrome P450 enzymes. Biochem Pharmacol. 44(11):2089-2098.
  • Smith DA, van de Waterbeemd H. 1999. Pharmacokinetics and metabolism in early drug discovery. Curr Opinion Chem Biol. 3(4):373-378.
  • Smith, D.A., Di, L. and Kerns, E.H., 2010. The effect of plasma protein binding on in vivo efficacy: misconceptions in drug discovery. Nature Rev. Drug. Disc., 9(12):929-939.
  • Smith, D.A. and Rowland, M., 2019. Intracellular and intraorgan concentrations of small molecule drugs: theory, uncertainties in infectious diseases and oncology, and promise. Drug Met Disp. 47(6):665-672.
  • Weininger D.1988. SMILES, a chemical language and information system. 1. Introduction to methodology and encoding rules. J. Chem Inf. Comp. Sci. 28(1): 1-36.
  • Weininger D, Weininger A, Weininger JL. 1989. SMILES. 2. Algorithm for generation of unique SMILES notation. J.Chem Inf Comp Sci. 29(2): 97-101.
  • Wiest DB, Cochran JB, Tecklenburg FW. 2012. Chloramphenicol toxicity revisited: a 12- year-old patient with a brain abscess. J Ped Pharmacol Therap. 17(2):182-188.
  • Zang Q,Mansouri K, Williams AJ, Judson RS, Allen DG, Casey WM, Kleinstreuer NC. 2017. In silico prediction of physicochemical properties of environmental chemicals using molecular fingerprints and machine learning. . J Chem Inf Model. 57(1):36-49.
  • Zhang Y, Deng Z, Xu X, Feng Y, Junliang S. 2023. Application of Artificial Intelligence in Drug–Drug Interactions Prediction: A Review. J Chem Inf Model .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.